Location History:
- Hayward, CA (US) (2010)
- Union City, CA (US) (2007 - 2012)
Company Filing History:
Years Active: 2007-2012
Title: Diane Feingersh: Innovator in Cancer Treatment
Introduction
Diane Feingersh is a prominent inventor based in Union City, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies for cancer treatment. With a total of 5 patents to her name, her work has the potential to impact the lives of many patients.
Latest Patents
One of her latest patents is focused on neutralizing human anti-IGFR antibodies. This invention includes fully human, neutralizing, monoclonal antibodies against the human Insulin-like Growth Factor Receptor-I (IGFR1). These antibodies are designed to be useful for treating or preventing cancer in a subject. Additionally, the patent outlines methods for using and producing these antibodies, showcasing her innovative approach to cancer therapy.
Career Highlights
Throughout her career, Diane has worked with notable companies such as Schering Corporation and Merck Sharp & Dohme Corporation. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the field of oncology.
Collaborations
Diane has collaborated with esteemed colleagues, including Yan Wang and Robert Greenberg. These partnerships have further enhanced her research and development efforts, leading to advancements in cancer treatment.
Conclusion
Diane Feingersh is a trailblazer in the field of biotechnology, with her innovative patents paving the way for new cancer therapies. Her dedication to research and collaboration with industry leaders exemplifies her commitment to improving patient outcomes.